ProQR Therapeutics N.V. (PRQR) Form 6-K — Jun 25, 2026
ProQR Therapeutics N.V. has entered into an underwriting agreement for a registered direct offering of 27,624,310 ordinary shares at a public offering price of $1.81 per share. The offering is being led by BofA Securities, Evercore Group, and Cantor Fitzgerald as representatives of the several underwriters. The company expects to generate aggregate net proceeds of approximately $46.5 million from the public offering, after deducting underwriting discounts and estimated offering expenses.
Key figures
- Offering Price
- 1.81
- Shares Offered
- 27624310
- Net proceeds public
- $46.5 million
- Private placement value
- $9.2 million
- Private placement shares
- 5100780
- Underwriter purchase price
- $1.7014
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.